HopeStage
Back to all studies
RecruitingNCT06378229

Psilocybin-assisted therapy for hospitalized people with treatment-resistant depression

About this titleRead the official source — NCT06378229
Medication studyAges 18+Belgium
The study in practice

Understand this study

Who could participate?

Listed age limits: from 18 years.

Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: May 21, 2024
Recruitment status
Recruiting
Enrollment listed in the registry
100
Sponsor
University Hospital, Ghent
Sponsor type
Hospital / academic medical center
Study type
Drug
Intervention type
Drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
Belgium
Age range
Over 18 Years
Official registry ID
NCT06378229
Official title
Show the full official title

Psilocybin-assisted Psychotherapy in the Treatment of Patients Hospitalized for Treatment-resistant Depression: an Open-label Feasibility Study with an Experiential and Systemic Focus

Recruitment & locations

Currently recruiting

Ghent

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is University Hospital, Ghent, a hospital or academic medical center.

Does this study involve medication?

Yes. The study involves medication, including Psilocybin.

Who can participate?

Listed age limits: from 18 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies